RESEARCH TRIANGLE PARK, N.C., Oct. 3, 2013 /PRNewswire/ -- Marken announced today the appointment of Michael Culme-Seymour to a new position as Vice President, Asia Pacific Region, effective October 14, 2013. Mr. Culme-Seymour will be responsible for clinical logistics and Marken's seven branches in the region, including: Singapore, Australia, India, China, Japan, Hong Kong and Korea.
Mr. Culme-Seymour has 22 years of logistics experience with airlines, express couriers and major post companies in Singapore, Zurich and London. He was most recently owner of Fischer Road Express Pte Ltd., a private company specializing in life science logistics. Prior to that, Mr. Culme-Seymour held senior executive positions in various companies including Singapore-based consulting firms, Deutsche Post Global Mail, DHL Global Mail, Swiss Cargo, DHL Express and International Bonded Couriers. He is British with 16 years overseas service and was a non-commissioned officer in the Royal Navy for 6 years.
"We are delighted to welcome Michael Culme-Seymour to Marken," said Wes Wheeler, Marken's Chief Executive Officer, "Michael brings extensive and practical expertise - and leadership - to our growing Asia Pacific region. We have spent the past two years making significant investments in the region, particularly India, China, Japan and Korea, which add to our already solid position in Singapore, Hong Kong and Australia. We see significant growth potential in the APAC region due to the shifts in clinical trial recruitment, the continued search for treatment-naive patients, the opening of China as a source of patients and the explosive growth of biosimilar drugs being sourced from these countries. Michael will work to expand Marken's growing presence in the region and contribute very well to our strategic plans."
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.